Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies (Q44332173)

2 December 2017

title

Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies (English)

1 reference

2 December 2017

2

1 reference

2 December 2017

6

Giorgio Bernardi

1 reference

2 December 2017

Paolo Calabresi

1

1 reference

2 December 2017

Letizia M Cupini

series ordinal

3

1 reference

2 December 2017

Cinzia Costa

series ordinal

4

1 reference

2 December 2017

Francesco Pisani

series ordinal

5

1 reference

2 December 2017

language of work or name

1 reference

1 February 2003

1 reference

2 December 2017

published in

Neurobiology of Disease

1 reference

2 December 2017

volume

12

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

82-88

1 reference

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Stroke treatment: promising but still struggling

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Lamotrigine Protects Hippocampal CA1 Neurons From Ischemic Damage After Cardiac Arrest

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Remacemide hydrochloride: a novel antiepileptic agent

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Pathobiology of ischaemic stroke: an integrated view

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Cerestat and other NMDA antagonists in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Does neuroprotection improve stroke outcome?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Current status and perspectives of neuroprotection in ischemic stroke treatment

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Update on the mechanism of action of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

A randomized, double-blind, placebo-controlled ascending dose tolerance study of 619C89 in acute stroke

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotection in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Ion homeostasis in rat brain in vivo: intra- and extracellular [Ca2 ] and [H ] in the hippocampus during recovery from short-term, transient ischemia

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Cerebroprotective effect of lamotrigine after focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

Sublethal Oxygen–Glucose Deprivation Alters Hippocampal Neuronal AMPA Receptor Expression and Vulnerability to Kainate-Induced Death

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(02)50016-5

7 January 2021

10.1016/S0969-9961(02)00016-5

Identifiers

DOI

1 reference

2 December 2017

1 reference